Chennai (Tamil Nadu) [India], September 17:

Kauvery Hospital, a leader in advanced cardiac care, has announced the launch of Fluoroless Ablation for Atrial Fibrillation, setting a new benchmark in the treatment of one of the most common heart rhythm disorders. Atrial fibrillation (AF) affects millions globally and poses significant health risks such as stroke, heart failure, and diminished quality of life. Symptoms including palpitations, fatigue, and shortness of breath can severely impact daily living. Kauvery Hospital continues to push the boundaries of medical innovation to ensure that patients receive the most effective and minimally invasive treatments available.

In line with this mission, Kauvery Hospital Alwarpet organized a landmark event titled “Update on Atrial Fibrillation,” featuring globally renowned expert, Dr Adam S. Budzikowski, Director of Cardiac Electrophysiology Services at SUNY Downstate Medical Center, New York. With over two decades of experience, Dr Budzikowski is at the forefront of breakthroughs in AF treatment. His presentation highlighted the remarkable advancements in electrophysiology (EP) that have transformed patient outcomes.
“Atrial fibrillation can now be managed with greater precision and safety. Procedures such as cardiac EP studies, ablation for atrial fibrillation, and left atrial appendage closures have revolutionized the way we treat this disorder. These techniques significantly improve patients’ quality of life by reducing symptoms and preventing complications,” Dr Budzikowski noted during his session.